As several health systems work toward a shared goal of reducing greenhouse gas emissions by 50% by 2030, some are rolling out sustainability efforts in their pharmacy departments. Charlottesville, Va.-based UVA Health introduced recyclable pill bottles in April. The containers…
The latest USP <797> chapter revisions, released in November 2023, require hospital-based compounding pharmacies to implement more stringent workflows and commit resources to comply with new standards, including: While many health systems have taken steps to address these new standards,…
An experimental cell therapy developed at the University of Wisconsin Health in Madison has received the FDA’s fast-track designation. The treatment, developed through a partnership between UW Health and the UW School of Medicine and Public Health, is designed to…
Walgreens is expanding its use of robotic micro fulfillment centers to handle prescription volume as part of a renewed push to streamline pharmacy operations and address staffing challenges, CNBC reported May 11. The company told the news outlet it plans…
Moderna’s new combination vaccine for seasonal influenza and COVID-19 has outperformed current standard vaccines in a large phase 3 clinical trial, showing stronger immune responses to both viruses in adults 50 years or older. The findings, published May 7 in…
A new fixed-dose combination therapy pairing obicetrapib with the cholesterol-lowering drug ezetimibe significantly reduced low-density lipoprotein (LDL) cholesterol levels in patients whose cholesterol remained elevated despite statin use, according to research published in The Lancet. The randomized, double-blind study enrolled…
The FDA is ramping up oversight of foreign manufacturing sites by expanding its use of unannounced inspections, a move aimed at leveling the playing field between domestic and international drugmakers, according to a May 6 news release from the agency. …
A new study showed that the experimental drug lorundrostat led to reductions in blood pressure in patients with uncontrolled hypertension already taking multiple medications. The randomized, placebo-controlled trial, the results of which were published April 23 in The New England…
The most expensive drug category for nonfederal hospitals in 2024 were antineoplastic targeted agents, according to a study published in the American Journal of Health-System Pharmacy. The report, published by the American Society of Health-System Pharmacists, found that U.S. drug…
The FDA has approved Johnson & Johnson’s drug Imaavy for the treatment of generalized myasthenia gravis, a chronic autoimmune neuromuscular disorder. The approval covers adults and pediatric patients 12 and older who test positive for anti-acetylcholine receptor or anti-muscle-specific kinase…
